Literature DB >> 27138846

Efficient and Controlled Generation of 2D and 3D Bile Duct Tissue from Human Pluripotent Stem Cell-Derived Spheroids.

Lipeng Tian1, Abhijeet Deshmukh1, Zhaohui Ye2, Yoon-Young Jang3,4.   

Abstract

While in vitro liver tissue engineering has been increasingly studied during the last several years, presently engineered liver tissues lack the bile duct system. The lack of bile drainage not only hinders essential digestive functions of the liver, but also leads to accumulation of bile that is toxic to hepatocytes and known to cause liver cirrhosis. Clearly, generation of bile duct tissue is essential for engineering functional and healthy liver. Differentiation of human induced pluripotent stem cells (iPSCs) to bile duct tissue requires long and/or complex culture conditions, and has been inefficient so far. Towards generating a fully functional liver containing biliary system, we have developed defined and controlled conditions for efficient 2D and 3D bile duct epithelial tissue generation. A marker for multipotent liver progenitor in both adult human liver and ductal plate in human fetal liver, EpCAM, is highly expressed in hepatic spheroids generated from human iPSCs. The EpCAM high hepatic spheroids can, not only efficiently generate a monolayer of biliary epithelial cells (cholangiocytes), in a 2D differentiation condition, but also form functional ductal structures in a 3D condition. Importantly, this EpCAM high spheroid based biliary tissue generation is significantly faster than other existing methods and does not require cell sorting. In addition, we show that a knock-in CK7 reporter human iPSC line generated by CRISPR/Cas9 genome editing technology greatly facilitates the analysis of biliary differentiation. This new ductal differentiation method will provide a more efficient method of obtaining bile duct cells and tissues, which may facilitate engineering of complete and functional liver tissue in the future.

Entities:  

Keywords:  3D tissue engineering; Ductal differentiation; Genome editing; Induced pluripotent stem cells; Liver progenitor; Spheroids

Mesh:

Substances:

Year:  2016        PMID: 27138846      PMCID: PMC6186008          DOI: 10.1007/s12015-016-9657-5

Source DB:  PubMed          Journal:  Stem Cell Rev Rep        ISSN: 2629-3277            Impact factor:   5.739


  24 in total

1.  Efficient generation of functional hepatocytes from human embryonic stem cells and induced pluripotent stem cells by HNF4α transduction.

Authors:  Kazuo Takayama; Mitsuru Inamura; Kenji Kawabata; Kazufumi Katayama; Maiko Higuchi; Katsuhisa Tashiro; Aki Nonaka; Fuminori Sakurai; Takao Hayakawa; Miho Kusuda Furue; Hiroyuki Mizuguchi
Journal:  Mol Ther       Date:  2011-11-08       Impact factor: 11.454

2.  Liver engraftment potential of hepatic cells derived from patient-specific induced pluripotent stem cells.

Authors:  Su Mi Choi; Yonghak Kim; Hua Liu; Pooja Chaudhari; Zhaohui Ye; Yoon-Young Jang
Journal:  Cell Cycle       Date:  2011-08-01       Impact factor: 4.534

Review 3.  Cholangiocyte biology.

Authors:  Pamela S Tietz; Nicholas F Larusso
Journal:  Curr Opin Gastroenterol       Date:  2006-05       Impact factor: 3.287

4.  Generation of endoderm-derived human induced pluripotent stem cells from primary hepatocytes.

Authors:  Hua Liu; Zhaohui Ye; Yonghak Kim; Saul Sharkis; Yoon-Young Jang
Journal:  Hepatology       Date:  2010-05       Impact factor: 17.425

5.  Directed differentiation of cholangiocytes from human pluripotent stem cells.

Authors:  Mina Ogawa; Shinichiro Ogawa; Christine E Bear; Saumel Ahmadi; Stephanie Chin; Bin Li; Markus Grompe; Gordon Keller; Binita M Kamath; Anand Ghanekar
Journal:  Nat Biotechnol       Date:  2015-07-13       Impact factor: 54.908

6.  In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration.

Authors:  Meritxell Huch; Craig Dorrell; Sylvia F Boj; Johan H van Es; Vivian S W Li; Marc van de Wetering; Toshiro Sato; Karien Hamer; Nobuo Sasaki; Milton J Finegold; Annelise Haft; Robert G Vries; Markus Grompe; Hans Clevers
Journal:  Nature       Date:  2013-01-27       Impact factor: 49.962

7.  Highly efficient differentiation of functional hepatocytes from human induced pluripotent stem cells.

Authors:  Xiaocui Ma; Yuyou Duan; Benjamin Tschudy-Seney; Garrett Roll; Iman Saramipoor Behbahan; Tijess P Ahuja; Vladimir Tolstikov; Charles Wang; Jeannine McGee; Shiva Khoobyari; Jan A Nolta; Holger Willenbring; Mark A Zern
Journal:  Stem Cells Transl Med       Date:  2013-05-16       Impact factor: 6.940

8.  Evaluation of differential gene expression by microarray analysis in small and large cholangiocytes isolated from normal mice.

Authors:  Yoshiyuki Ueno; Gianfranco Alpini; Kaichiro Yahagi; Noriatsu Kanno; Yuki Moritoki; Koji Fukushima; Shannon Glaser; Gene LeSage; Tooru Shimosegawa
Journal:  Liver Int       Date:  2003-12       Impact factor: 5.828

Review 9.  Applications of patient-specific induced pluripotent stem cells; focused on disease modeling, drug screening and therapeutic potentials for liver disease.

Authors:  Yong Soon Chun; Pooja Chaudhari; Yoon-Young Jang
Journal:  Int J Biol Sci       Date:  2010-12-14       Impact factor: 6.580

10.  Long-term culture of genome-stable bipotent stem cells from adult human liver.

Authors:  Meritxell Huch; Helmuth Gehart; Ruben van Boxtel; Karien Hamer; Francis Blokzijl; Monique M A Verstegen; Ewa Ellis; Martien van Wenum; Sabine A Fuchs; Joep de Ligt; Marc van de Wetering; Nobuo Sasaki; Susanne J Boers; Hans Kemperman; Jeroen de Jonge; Jan N M Ijzermans; Edward E S Nieuwenhuis; Ruurdtje Hoekstra; Stephen Strom; Robert R G Vries; Luc J W van der Laan; Edwin Cuppen; Hans Clevers
Journal:  Cell       Date:  2014-12-18       Impact factor: 41.582

View more
  13 in total

Review 1.  Expression kinetics of hepatic progenitor markers in cellular models of human liver development recapitulating hepatocyte and biliary cell fate commitment.

Authors:  Pooja Chaudhari; Lipeng Tian; Abhijeet Deshmukh; Yoon-Young Jang
Journal:  Exp Biol Med (Maywood)       Date:  2016-07-06

Review 2.  Human-relevant preclinical in vitro models for studying hepatobiliary development and liver diseases using induced pluripotent stem cells.

Authors:  Pooja Chaudhari; Lipeng Tian; Zhaohui Ye; Yoon-Young Jang
Journal:  Exp Biol Med (Maywood)       Date:  2019-02-26

3.  A process engineering approach to increase organoid yield.

Authors:  Natasha Arora; Jasmin Imran Alsous; Jacob W Guggenheim; Michael Mak; Jorge Munera; James M Wells; Roger D Kamm; H Harry Asada; Stanislav Y Shvartsman; Linda G Griffith
Journal:  Development       Date:  2017-02-07       Impact factor: 6.868

Review 4.  CRISPR/Cas9: at the cutting edge of hepatology.

Authors:  Francis P Pankowicz; Kelsey E Jarrett; William R Lagor; Karl-Dimiter Bissig
Journal:  Gut       Date:  2017-05-09       Impact factor: 23.059

Review 5.  Convergence of human pluripotent stem cell, organoid, and genome editing technologies.

Authors:  Lin Wang; Zhaohui Ye; Yoon-Young Jang
Journal:  Exp Biol Med (Maywood)       Date:  2021-01-19

Review 6.  Intestinal organoids: roadmap to the clinic.

Authors:  Magdalena Kasendra; Misty Troutt; Taylor Broda; W Clark Bacon; Timothy C Wang; Joyce C Niland; Michael A Helmrath
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2021-05-05       Impact factor: 4.871

Review 7.  Organoids and Spheroids as Models for Studying Cholestatic Liver Injury and Cholangiocarcinoma.

Authors:  Burcin Ekser; Gianfranco Alpini; Keisaku Sato; Wenjun Zhang; Samira Safarikia; Abdulkadir Isidan; Angela M Chen; Ping Li; Heather Francis; Lindsey Kennedy; Leonardo Baiocchi; Domenico Alvaro; Shannon Glaser
Journal:  Hepatology       Date:  2021-06-04       Impact factor: 17.298

8.  Development and characterization of cholangioids from normal and diseased human cholangiocytes as an in vitro model to study primary sclerosing cholangitis.

Authors:  Lorena Loarca; Thiago M De Assuncao; Nidhi Jalan-Sakrikar; Steve Bronk; Anuradha Krishnan; Bing Huang; Leslie Morton; Christy Trussoni; Lorena Marcano Bonilla; Eugene Krueger; Steve O'Hara; Patrick Splinter; Guang Shi; María José Lorenzo Pisarello; Gregory J Gores; Robert C Huebert; Nicholas F LaRusso
Journal:  Lab Invest       Date:  2017-09-11       Impact factor: 5.662

9.  Biliary Atresia Relevant Human Induced Pluripotent Stem Cells Recapitulate Key Disease Features in a Dish.

Authors:  Lipeng Tian; Zhaohui Ye; Kim Kafka; Dylan Stewart; Robert Anders; Kathleen B Schwarz; Yoon-Young Jang
Journal:  J Pediatr Gastroenterol Nutr       Date:  2019-01       Impact factor: 2.839

Review 10.  Mechanisms Underlying Cell Therapy in Liver Fibrosis: An Overview.

Authors:  Daphne Pinheiro; Isabelle Dias; Karina Ribeiro Silva; Ana Carolina Stumbo; Alessandra Thole; Erika Cortez; Lais de Carvalho; Ralf Weiskirchen; Simone Carvalho
Journal:  Cells       Date:  2019-10-29       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.